FUNCTIONALIZED FURAN-2-SULFONAMIDES EXHIBITING ENDOTHELIAL LIPASE INHIBITION

The present invention relates to pharmaceutical compositions comprising furan-2-sulfonamide derivatives. The present invention further relates to methods of treatment of diseases or conditions associated with endothelial lipase activity, including coronary artery disease and low HDL-C.

Saved in:
Bibliographic Details
Main Authors MEYERS, HAROLD, CHILDERS, WAYNE E, MARTINEZ, ROGELIO L, ABOU-GHARBIA, MAGID, ELSHOURBAGY, NABIL, GHIDU, VICTOR P, MOUSA, SHAKER A
Format Patent
LanguageEnglish
French
German
Published 17.08.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to pharmaceutical compositions comprising furan-2-sulfonamide derivatives. The present invention further relates to methods of treatment of diseases or conditions associated with endothelial lipase activity, including coronary artery disease and low HDL-C.
Bibliography:Application Number: EP20140851805